Ixekizumab real-world effectiveness at 24 weeks in patients with psoriasis: Data from the United States Taltz Customer Support Program

被引：0
|
作者：
Gottlieb, Alice [1 ]
Burge, Russel [2 ]
Malatestinic, William [2 ]
Zhu, Baojin [2 ]
Guo, Jiaying [2 ]
Zhao, Yunyang [3 ]
McCormack, Julie
Kimel, Miriam [2 ]
Feely, Meghan
Merola, Joseph [4 ,5 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Brightech Int LLC, Somerset, NJ USA
[4] Harvard Med Sch, Dept Dermatol, Boston, MA USA
[5] Harvard Med Sch, Dept Med, Div Rheumatol, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
43015
引用
收藏
页码：AB185 / AB185
页数：1
相关论文
共 50 条
  • [1] Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program
    Alice B. Gottlieb
    Russel Burge
    William N. Malatestinic
    Baojin Zhu
    Yunyang Zhao
    Julie McCormack
    Miriam Kimel
    Joseph F. Merola
    [J]. Dermatology and Therapy, 2023, 13 : 1831 - 1846
  • [2] Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program
    Gottlieb, Alice B.
    Burge, Russel
    Malatestinic, William N.
    Zhu, Baojin
    Zhao, Yunyang
    McCormack, Julie
    Kimel, Miriam
    Merola, Joseph F.
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (08) : 1831 - 1846
  • [3] REAL-WORLD DATA ON THE EFFICACY AND SAFETY OF IXEKIZUMAB IN PATIENTS WITH PLAQUE PSORIASIS
    Stefanaki, Irene
    Rompoti, Natalia
    Panagakis, Pantelis
    Papoutsaki, Marina
    Politou, Maria
    Vavouli, Charitomeni
    Mpefon, Aggeliki
    Fiori, Kousta
    Eleni, Lazou
    Zaimi, Maria
    Koumprentziotis, Ioannis-Alexios
    Zafeiropoulou, Theodora
    Chasapi, Vasiliki
    Stratigos, Alexander
    Nicolaidou, Electra
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [4] Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania
    Bucur, Stefana
    Serban, Elena-Daniela
    Ileanu, Bogdan Vasile
    Costache, Raluca Simona
    Nicolescu, Alin Codrut
    Constantin, Traian
    Costache, Daniel Octavian
    Constantin, Maria -Magdalena
    [J]. PSORIASIS-TARGETS AND THERAPY, 2024, 14 : 79 - 86
  • [5] Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience
    Gonulal, Melis
    Altunay, Ilknur Kivanc
    Dogan, Sinan
    Turkmen, Meltem
    Balci, Didem Didar
    Ozturkcan, Serap
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [6] Real-World Effectiveness of Belimumab in Patients with SLE in the United States
    Bell, Christopher
    Rubin, Bernie
    Worley, Karen
    Germain, Guillaume
    Laliberte, Francois
    MacKnight, Sean D.
    Urosevic, Ana
    Duh, Mei Sheng
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 685 - 686
  • [7] Early real-world effectiveness of secukinumab in the treatment of psoriasis in Canada: Retrospective analysis of patient support program data
    Vender, Ronald
    Yanofsky, Howard
    Boucher, Annie
    Hashmonay, Ron
    Schmid, Simon
    Chiva-Razavi, Sima
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB107 - AB107
  • [8] EFFECTIVENESS OF IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A REAL-WORLD EUROPEAN SURVEY
    Tillett, W.
    Navarro-Compan, V.
    Booth, N.
    Holzkaemper, T.
    Hill, J.
    Lubrano, E.
    Truer, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1307 - 1308
  • [9] Efficacy and safety of ixekizumab in real-world psoriasis patients: A retrospective unicentre study
    Sendin-Martin, Mercedes
    Rodriguez, Lourdes
    Barabash-Neila, Roman
    Jose Duran-Romero, Antonio
    Conejo-Mir Sanchez, Julian
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB163 - AB163
  • [10] Healthcare Costs Among Patients with Psoriasis Treated with Ixekizumab Versus Secukinumab in Real-World Settings Over 24 Months
    Blauvelt, Andrew
    Shi, Nianwen
    Burge, Russel
    Atiya, Bilal
    Zhu, Baojin
    Somani, Najwa
    Ridenour, Terri
    Lew, Carolyn R.
    Zimmerman, Nicole M.
    Murage, Mwangi J.
    [J]. PHARMACOECONOMICS-OPEN, 2022, 6 (06) : 871 - 880
12345